The effect of dopamine on MPTP-induced rotarod disability

被引:28
作者
Ayton, Scott [1 ]
George, Jessica L. [1 ]
Adlard, Paul A. [1 ]
Bush, Ashley I. [1 ]
Cherny, Robert A. [1 ]
Finkelstein, David I. [1 ]
机构
[1] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia
基金
澳大利亚研究理事会; 英国医学研究理事会;
关键词
Parkinson's disease; MPTP; Dopamine; Rotarod; PARKINSONS-DISEASE; MOUSE MODEL; INDUCED DYSKINESIA; SUBSTANTIA-NIGRA; MICE; MOTOR; NEUROTOXICITY; BEHAVIOR; EXTRACT; NEURONS;
D O I
10.1016/j.neulet.2013.02.066
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Dopamine depletion in Parkinson's disease (PD) results in bradykinesia and tremor. Therapeutic administration of the dopamine precursor, L-Dopa, alleviates these symptoms but dyskinesia's can manifest with chronic treatment. In the MPTP toxin mouse model of PD, lesion severity is often assessed by the rotarod behavioral assay. Dopamine depletion by MPTP is thought to induce rotarod behavioral decline. Here we surveyed rotarod behavior and striatal dopamine at timed intervals post-MPTP. Paradoxically, rotarod disability coincided with gradual striatal dopamine restoration. L-Dopa supplementation exacerbated rotarod disability, whereas dopamine antagonism restored performance. Conclusion: dopamine restoration, not depletion, precipitates rotarod disability after MPTP intoxication, and caution should be applied when using this assay for MPTP. (C) 2013 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:105 / 109
页数:5
相关论文
共 26 条
[1]   Sex differences in motor behavior in the MPTP mouse model of Parkinson's disease [J].
Antzoulatos, Eleni ;
Jakowec, Michael W. ;
Petzinger, Giselle M. ;
Wood, Ruth I. .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2010, 95 (04) :466-472
[2]   Inactivation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) [J].
Ara, J ;
Przedborski, S ;
Naini, AB ;
Jackson-Lewis, V ;
Trifiletti, RR ;
Horwitz, J ;
Ischiropoulos, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (13) :7659-7663
[3]   Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia [J].
Aubert, I ;
Guigoni, C ;
Håkansson, K ;
Li, Q ;
Dovero, S ;
Barthe, N ;
Bioulac, BH ;
Gross, CE ;
Fisone, G ;
Bloch, B ;
Bezard, E .
ANNALS OF NEUROLOGY, 2005, 57 (01) :17-26
[4]  
Bezard E, 2000, SYNAPSE, V38, P363, DOI 10.1002/1098-2396(20001201)38:3<363::AID-SYN16>3.3.CO
[5]  
2-1
[6]  
Burch D, 2005, LANCET, V365, P622
[7]   A PRIMATE MODEL OF PARKINSONISM - SELECTIVE DESTRUCTION OF DOPAMINERGIC-NEURONS IN THE PARS COMPACTA OF THE SUBSTANTIA NIGRA BY N-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE [J].
BURNS, RS ;
CHIUEH, CC ;
MARKEY, SP ;
EBERT, MH ;
JACOBOWITZ, DM ;
KOPIN, IJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (14) :4546-4550
[8]   Dopamine dysregulation of movement control in L-DOPA-induced dyskinesia [J].
Cenci, M. Angela .
TRENDS IN NEUROSCIENCES, 2007, 30 (05) :236-243
[9]   EFFECTS OF L-DOPA ON NOREPINEPHRINE METABOLISM IN BRAIN [J].
CHALMERS, JP ;
BALDESSARINI, RJ ;
WURTMAN, RJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1971, 68 (03) :662-+
[10]   EFFECTS OF MPTP ON LOCOMOTOR-ACTIVITY IN MICE [J].
COLOTLA, VA ;
FLORES, E ;
OSCOS, A ;
MENESES, A ;
TAPIA, R .
NEUROTOXICOLOGY AND TERATOLOGY, 1990, 12 (04) :405-407